- Home
- AUPH vs SEDG Comparison
AUPH vs SEDG Comparison
Compare AUPH & SEDG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AUPH | SEDG |
|---|---|---|
| Founded | 1993 | 2006 |
| Country | Canada | Israel |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Semiconductors |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.1B | 1.9B |
| IPO Year | 2014 | 2015 |
Fundamental Metrics
Financial Performance| Metric | AUPH | SEDG |
|---|---|---|
| Price | $16.73 | $33.64 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 7 | 25 |
| Target Price | $17.86 | ★ $37.84 |
| AVG Volume (30 Days) | 737.0K | ★ 2.3M |
| Earning Date | 11-03-2026 | 11-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 5075.00 | 78.26 |
| EPS | ★ 0.53 | N/A |
| Revenue | $283,055,000.00 | ★ $1,184,444,000.00 |
| Revenue This Year | $15.83 | $9.81 |
| Revenue Next Year | $21.30 | $10.13 |
| P/E Ratio | $31.62 | ★ N/A |
| Revenue Growth | 20.38 | ★ 31.39 |
| 52 Week Low | $11.48 | $28.21 |
| 52 Week High | $19.25 | $81.25 |
Technical Indicators
Market Signals| Indicator | AUPH | SEDG |
|---|---|---|
| Relative Strength Index (RSI) | 57.21 | 53.08 |
| Support Level | $15.61 | $32.49 |
| Resistance Level | $17.02 | $35.08 |
| Average True Range (ATR) | 0.40 | 1.76 |
| MACD | 0.05 | 0.18 |
| Stochastic Oscillator | 68.77 | 73.00 |
Price Performance
Historical ComparisonAbout AUPH Aurinia Pharmaceuticals Inc
Aurinia Pharmaceuticals Inc is a biopharmaceutical company focused on delivering therapies to people living with autoimmune diseases with high unmet medical needs. The company developed LUPKYNIS (voclosporin), the first FDA-approved oral therapy for the treatment of adult patients with active lupus nephritis. It is also developing aritinercept, a dual inhibitor of B cell activating factor (BAFF) and a proliferation-inducing ligand (APRIL), for the potential treatment of autoimmune diseases.
About SEDG SolarEdge Technologies Inc.
SolarEdge Technologies designs, develops, and sells direct current optimized inverter systems for solar photovoltaic installations. The company system consists of power optimizers, inverters, and cloud-based monitoring platform and addresses a broad range of solar market segments, from residential solar installations to commercial and small utility-scale solar installations. The company sells its products directly to solar installers, engineering, procurement, and construction firms and indirectly to solar installers through distributors and electrical equipment wholesalers.